12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

ExonHit genomics, pharmacogenetics news

ExonHit joined the RESPONSIFY consortium and received a €418,000 ($551,509) grant under the European Commission's Framework Programme 7 (FP7). ExonHit will work with academic and industry partners to develop its Genome Wide SpliceArray (GWSA) technology to analyze cancer patients' transcriptomic profiles. RESPONSIFY, which comprises...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >